Bioray Biotech Co., Ltd
Bioray Biotech Co., Ltd engages in the production, research, and sells health foods, immune cell products, and precision testing services in Taiwan. It offers health care products, including various functional foods and supplements; medicinal fungi; immune cell products; and precision medicine services, such as immunology, cell division, and specialized laboratory testing. The company is also inv… Read more
Market Cap & Net Worth: Bioray Biotech Co., Ltd (7561)
Bioray Biotech Co., Ltd (TWO:7561) has a market capitalization of $20.03 Million (NT$662.71 Million) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #28638 globally and #1795 in its home market, demonstrating a -6.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioray Biotech Co., Ltd's stock price NT$22.40 by its total outstanding shares 29585262 (29.59 Million).
Bioray Biotech Co., Ltd Market Cap History: 2026 to 2026
Bioray Biotech Co., Ltd's market capitalization history from 2026 to 2026. Data shows growth from $20.03 Million to $20.03 Million (0.00% CAGR).
Bioray Biotech Co., Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioray Biotech Co., Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7561 by Market Capitalization
Companies near Bioray Biotech Co., Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Bioray Biotech Co., Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Bioray Biotech Co., Ltd Historical Marketcap From 2026 to 2026
Between 2026 and today, Bioray Biotech Co., Ltd's market cap moved from $20.03 Million to $ 20.03 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$20.03 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Bioray Biotech Co., Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.03 Million USD |
| MoneyControl | $20.03 Million USD |
| MarketWatch | $20.03 Million USD |
| marketcap.company | $20.03 Million USD |
| Reuters | $20.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.